Long-term Efficacy and Safety of Carbon-ion Radiotherapy for Thoracic Chordoma: A Case Report
Authors:
Open Access
- 27 June 2025
- journal article
- case report
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 39 (4) , 2429-2435
Abstract
We report a case of inoperable thoracic chordoma successfully treated with carbon-ion radiotherapy (C-ion RT). A 65-year-old male patient underwent computed tomography for evaluation of a benign thyroid nodule and was incidentally diagnosed with thoracic chordoma without metastasis. A physical examination revealed increased tendon reflexes in the lower extremities. Magnetic resonance imaging revealed a tumour measuring 52 mm in maximum diameter, located from the seventh cervical to the third thoracic vertebrae, compressing a wide area of the spinal cord. The patient was unsuitable for surgery due to the high risk of severe postoperative neurological dysfunction. The patient received C-ion RT at a total dose of 64.0 Gy (relative biological effectiveness), delivered in 16 fractions. The patient completed C-ion RT as scheduled; however, the patient experienced transient Lhermitte's sign, classified as grade 1 acute neuropathy, during treatment. The patient is alive 96 months after C-ion RT initiation with no evidence of local recurrence or distant metastasis, remains ambulatory, and has developed no grade 2 or higher toxicities other than the grade 1 neuropathy that was present prior to the initiation of C-ion RT. We observed a favourable local response with manageable toxicity in a patient with thoracic chordoma treated with C-ion RT. Although this is a single-case report, our findings suggest that C-ion RT could be considered a viable treatment option for thoracic chordomas.Keywords
This publication has 17 references indexed in Scilit:
- Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic ReviewFrontiers in Oncology, 2019
- Surgical management of chordoma: A systematic reviewThe Journal of Spinal Cord Medicine, 2018
- Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2018
- Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 CasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2016
- Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, JapanPhysics in Medicine & Biology, 2015
- Effect of Carbon Ion Radiotherapy for Sacral Chordoma: Results of Phase I-II and Phase II Clinical TrialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Benign Notochordal Cell Tumors: A Comparative Histological Study of Benign Notochordal Cell Tumors, Classic Chordomas, and Notochordal Vestiges of Fetal Intervertebral DiscsAmerican Journal of Surgical Pathology, 2004
- Chordoma: incidence and survival patterns in the United States, 1973–1995Cancer Causes & Control, 2001